Yali Zhang

Yali Zhang

Auto-generated profile, based on publicly available information

Yali Zhang

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, P.R. China; National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, P.R. China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2021 in Science Translational Medicine
Verified
Journal Article
Open access
YWYangtao Wu
Yangtao Wu
XHXiaofen Huang
Xiaofen Huang
LYLunzhi Yuan
Lunzhi Yuan
SWShaojuan Wang
Shaojuan Wang
YZYali Zhang
Yali Zhang
NXNingshao Xia
Ningshao Xia
A SARS-CoV-2 spike protein subunit vaccine induced humoral and cellular immune responses that protected hamsters against infection and prevented transmission.

7 March 2022 in Cell Reports
Verified
Journal Article
Open access
YZYali Zhang
Yali Zhang
MWMin Wei
Min Wei
YWYangtao Wu
Yangtao Wu
JWJuan Wang
Juan Wang
YHYuting Hong
Yuting Hong
NXNingshao Xia
Ningshao Xia
Mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain (RBD) may alter viral host tropism and affect the activities of neutralizing antibodies. Here, we investigated 153 RBD mutants and 11 globally circulating variants of concern (VOCs) and variants of interest (VOIs) (including Omicron) for their antigenic changes and cross-species tropism in cells expressing 18 ACE2 orthologs. Several RBD mutations strengthened viral infectivity in cells expressing ACE2 orthologs of non-human animals, particularly those less susceptible to the ancestral strain. The mutations surrounding amino acids (aas) 439–448 and aa 484 are more likely to cause neutralization resistance. Strikingly, enhanced cross-species infection potential in the mouse and ferret, instead of the neutralization-escape scores of the mutations, account for the positive correlation with the cumulative prevalence of mutations in humans. These findings present insights for potential drivers of circulating SARS-CoV-2 variants and provide informative parameters for tracking and forecasting spreading mutations.